News & Events about Exact Sciences Corporation.
Exact Sciences schedules first quarter 2023 earnings call Exact Sciences schedules first quarter 2023 earnings call PR Newswire MADISON, Wis., April 10, 2023 MADISON, Wis., April 10, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic...
TheStreet.com - Investing
1month ago
Her flagship Ark Innovation ETF has slumped 38% over the past year, but has rebounded 23% so far this year.Her flagship Ark Innovation ETF has slumped 38% over the past year, but has rebounded 23% so far this year.If youve followed Cathie Woods trades in recent months, youve undoubtedly noticed that...
Exact Sciences (NASDAQ:EXAS Get Rating) had its price objective hoisted by Piper Sandler from $50.00 to $70.00 in a report issued on Friday, The Fly reports. They currently have a neutral rating on the medical research companys stock. A number of other equities research analysts also recently issued...
Ticker Report
3 months ago
Exact Sciences Co. (NASDAQ:EXAS Get Rating) CEO Kevin T. Conroy sold 14,617 shares of Exact Sciences stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $65.59, for a total value of $958,729.03. Following the completion of the transaction, the chief ...
Exact Sciences Co. (NASDAQ:EXAS Get Rating) CEO Kevin T. Conroy sold 14,617 shares of Exact Sciences stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $65.59, for a total value of $958,729.03. Following the completion of the transaction, the chief ...